To evaluate the stemness of MYBL2-expressing melanoma cells, we downloaded and converted melanoma RNA-Seq (FPKM) data to TPM and normalized the data log2 (TPM+1), while keeping samples with clinical information recorded. The gene discussed is MYBL2; the disease is melanoma.